Research article Special Issues

Effects of Short Term Hypoxia-Preconditioning on Glial Phenotype Induction of Human Mesenchymal Stem Cells

  • Development of successful clinical treatments for peripheral nerve injury is limited due to the complications behind neural physiology. Human mesenchymal stem cells (hMSCs) have the ability to directly promote tissue repair and protect cells at the injury site. Studies have shown that hMSCs can be transplanted to improve nerve regeneration. Hypoxic culture condition has been proven to maintain the stemness of hMSCs for later differentiation. In this study, we investigated the effects of low oxygen (O2) (2% and 5% O2) pre-treatment and initial seeding density (500, 1000, and 2000 cells/cm2) on glial protein expression during glial differentiation of hMSCs. Results showed that the secretion of glial proteins was tunable by modifying the seeding density. Moreover, glial induction of hMSCs, characterized by the glial fibrillary acidic protein (GFAP) and S100β expressing phenotype, were enhanced by short-term hypoxia pretreatment. The significantly increased gene expression, including GFAP (10 folds in 2% O2, 25 folds in 5% O2), 2’,3’-Cyclic Nucleotide 3’ Phosphodiesterase (CNP) (600 folds in 2% O2, 800 folds in 5% O2), and neural growth factor receptor (NGFR) (4 folds in 5% O2), indicated that low oxygen, especially 5% O2 pretreated hMSCs had an improved potential for peripheral nerve regeneration.

    Citation: Zichen Qian, Qi Xing, Corey Fase, Kyle Jansen, Feng Zhao. Effects of Short Term Hypoxia-Preconditioning on Glial Phenotype Induction of Human Mesenchymal Stem Cells[J]. AIMS Cell and Tissue Engineering, 2017, 1(1): 47-63. doi: 10.3934/celltissue.2017.1.47

    Related Papers:

  • Development of successful clinical treatments for peripheral nerve injury is limited due to the complications behind neural physiology. Human mesenchymal stem cells (hMSCs) have the ability to directly promote tissue repair and protect cells at the injury site. Studies have shown that hMSCs can be transplanted to improve nerve regeneration. Hypoxic culture condition has been proven to maintain the stemness of hMSCs for later differentiation. In this study, we investigated the effects of low oxygen (O2) (2% and 5% O2) pre-treatment and initial seeding density (500, 1000, and 2000 cells/cm2) on glial protein expression during glial differentiation of hMSCs. Results showed that the secretion of glial proteins was tunable by modifying the seeding density. Moreover, glial induction of hMSCs, characterized by the glial fibrillary acidic protein (GFAP) and S100β expressing phenotype, were enhanced by short-term hypoxia pretreatment. The significantly increased gene expression, including GFAP (10 folds in 2% O2, 25 folds in 5% O2), 2’,3’-Cyclic Nucleotide 3’ Phosphodiesterase (CNP) (600 folds in 2% O2, 800 folds in 5% O2), and neural growth factor receptor (NGFR) (4 folds in 5% O2), indicated that low oxygen, especially 5% O2 pretreated hMSCs had an improved potential for peripheral nerve regeneration.


    加载中
    [1] Traffic Safety Facts 2013 Data, in Traffic Safety Facts. 2015, U.S. Department of Transportation.
    [2] CPSC's National Electronic Injury Surveillance System (NEISS) Data Highlights 2014. 2015, CPSC: CPSC.
    [3] Henry JL (2014) Mechanisms of Peripheral Nerve Injury – What to Treat, When to Treat. Peripheral Neuropathy. Intech.
    [4] Lim TK, Shi XQ, Johnson JM, et al. (2015) Peripheral nerve injury induces persistent vascular dysfunction and endoneurial hypoxia, contributing to the genesis of neuropathic pain. J Neurosci Off J Soc Neurosci 35: 3346-3359. doi: 10.1523/JNEUROSCI.4040-14.2015
    [5] Waller A (1850) Experiments on the Section of the Glossopharyngeal and Hypoglossal Nerves of the Frog, and Observations of the Alterations Produced Thereby in the Structure of Their Primitive Fibres. Philos Trans R Soc London 140: 423-429. doi: 10.1098/rstl.1850.0021
    [6] Kuffler DP (2014) An assessment of current techniques for inducing axon regeneration and neurological recovery following peripheral nerve trauma. Prog Neurobiol 116: 1-12. doi: 10.1016/j.pneurobio.2013.12.004
    [7] Gu X, Ding F, Yang Y, et al. (2011) Construction of tissue engineered nerve grafts and their application in peripheral nerve regeneration. Prog Neurobiol 93: 204-230. doi: 10.1016/j.pneurobio.2010.11.002
    [8] Mothe AJ, Tam RY, Zahir T, et al. (2013) Repair of the injured spinal cord by transplantation of neural stem cells in a hyaluronan-based hydrogel. Biomaterials 34: 3775-3783. doi: 10.1016/j.biomaterials.2013.02.002
    [9] Xing Q, Vogt C, Leong KW, et al. (2014) Highly Aligned Nanofibrous Scaffold Derived from Decellularized Human Fibroblasts. Adv Funct Mater 24: 3027. doi: 10.1002/adfm.201303460
    [10] Yuan SH, Shaner M (2013) Bioengineered stem cells in neural development and neurodegeneration research. Ageing Res Rev 12: 739-748. doi: 10.1016/j.arr.2013.04.002
    [11] Walsh S, Midha R (2009) Practical considerations concerning the use of stem cells for peripheral nerve repair. Neurosurg Focus 26: E2.
    [12] Park JH, Kim DY, Sung IY, et al. (2012) Long-term Results of Spinal Cord Injury Therapy Using Mesenchymal Stem Cells Derived From Bone Marrow in Humans. Neurosurg 70: 1238-1247. doi: 10.1227/NEU.0b013e31824387f9
    [13] Parekkadan B, Milwid JM (2010) Mesenchymal Stem Cells as Therapeutics. Annu Rev Biomed Eng 12: 87-117. doi: 10.1146/annurev-bioeng-070909-105309
    [14] Ortiz LA, Gambelli F, McBride C, et al. (2003) Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 100: 8407-8411. doi: 10.1073/pnas.1432929100
    [15] Rojas M, Xu J, Woods CR, et al. (2005) Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33: 145-152. doi: 10.1165/rcmb.2004-0330OC
    [16] Jiang Y, Jahagirdar BN, Reinhardt RL, et al. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41-49. doi: 10.1038/nature00870
    [17] Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. (1999) Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5: 309-313. doi: 10.1038/6529
    [18] Lazarus HM, Haynesworth SE, Gerson SL, et al. (1995) Ex-Vivo Expansion and Subsequent Infusion of Human Bone-Marrow-Derived Stromal Progenitor Cells (Mesenchymal Progenitor Cells): Implications for Therapeutic Use. Bone Marrow Transplant 16: 557-564.
    [19] Brohlin M, Mahay D, Novikov LN, et al. (2009) Characterisation of human mesenchymal stem cells following differentiation into Schwann cell-like cells. Neurosci Res 64: 41-49. doi: 10.1016/j.neures.2009.01.010
    [20] Prabhakaran MP, Venugopal JR, Ramakrishna S (2009) Mesenchymal stem cell differentiation to neuronal cells on electrospun nanofibrous substrates for nerve tissue engineering. Biomaterials 30: 4996-5003. doi: 10.1016/j.biomaterials.2009.05.057
    [21] KEILHOFF G, GOIHL A, STANG F, et al. (2006) Peripheral Nerve Tissue Engineering: Autologous Schwann Cells vs. Transdifferentiated Mesenchymal Stem Cells. Tissue Eng 12: 16.
    [22] Chen A, Siow B, Blamire AM, et al. (2010) Transplantation of magnetically labeled mesenchymal stem cells in a model of perinatal brain injury. Stem Cell Res 5: 255-266. doi: 10.1016/j.scr.2010.08.004
    [23] Chen CJ, Ou YC, Liao SL, et al. (2007) Transplantation of bone marrow stromal cells for peripheral nerve repair. Exp Neurol 204: 443-453. doi: 10.1016/j.expneurol.2006.12.004
    [24] Kofoed H, Sjontoft E, Siemssen SO, et al. (1985) Bone marrow circulation after osteotomy. Blood flow, pO2, pCO2, and pressure studied in dogs. Acta Orthop Scand 56: 400-403.
    [25] D'Ippolito G, Diabira S, Howard GA, et al. (2006) Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells. Bone 39: 513-522. doi: 10.1016/j.bone.2006.02.061
    [26] Sethe S, Scutt A, Stolzing A (2006) Aging of mesenchymal stem cells. Ageing Res Rev 5: 91-116. doi: 10.1016/j.arr.2005.10.001
    [27] Das R, Jahr H, van Osch GJVM, et al. (2010) The Role of Hypoxia in Bone Marrow-Derived Mesenchymal Stem Cells: Considerations for Regenerative Medicine Approaches. Tissue Eng Part B 16: 159-168. doi: 10.1089/ten.teb.2009.0296
    [28] Hutton DL, Logsdon EA, Moore EM, et al. (2012) Vascular morphogenesis of adipose-derived stem cells is mediated by heterotypic cell-cell interactions. Tissue Eng Part A 18: 1729-1740. doi: 10.1089/ten.tea.2011.0599
    [29] Xue R, Li JY, Yeh Y, et al. (2013) Effects of matrix elasticity and cell density on human mesenchymal stem cells differentiation. J Orthop Res Off Publ Orthop Res Soc 31: 1360-1365. doi: 10.1002/jor.22374
    [30] Ashton RS (2007) Engineering Biomaterials for the Investigation of Factors that Influence Stem Cell Fate. Rensselaer Polytechnic Institute: ProQuest. p. 121.
    [31] Wernicke JF, Volpe JJ (1986) Glial differentiation in dissociated cell cultures of neonatal rat brain: noncoordinate and density-dependent regulation of oligodendroglial enzymes. J Neurosci Res 15: 39-47. doi: 10.1002/jnr.490150105
    [32] Xing Q, Qian Z, Kannan B, et al. (2015) Osteogenic Differentiation Evaluation of an Engineered Extracellular Matrix Based Tissue Sheet for Potential Periosteum Replacement. ACS Appl Mater Interfaces 7.
    [33] Zhang L, Xing Q, Qian Z, et al. (2016) Hypoxia Created Human Mesenchymal Stem Cell Sheet for Prevascularized 3D Tissue Construction. Adv Healthc Mater 5: 342-352. doi: 10.1002/adhm.201500744
    [34] Jensen EC (2013) Quantitative analysis of histological staining and fluorescence using ImageJ. Anat Rec 296: 378-381. doi: 10.1002/ar.22641
    [35] Tohill M, Mantovani C, Wiberg M, et al. (2004) Rat bone marrow mesenchymal stem cells express glial markers and stimulate nerve regeneration. Neurosci Lett 362: 200-203. doi: 10.1016/j.neulet.2004.03.077
    [36] Grayson WL, Zhao F, Bunnell B, et al. (2007) Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun 358: 948-953. doi: 10.1016/j.bbrc.2007.05.054
    [37] Raponi E, Agenes F, Delphin C, et al. (2007) S100B expression defines a state in which GFAP-expressing cells lose their neural stem cell potential and acquire a more mature developmental stage. Glia 55: 165-177. doi: 10.1002/glia.20445
    [38] Kesherwani V, Tarang S, Barnes R, et al. (2014) Fasudil reduces GFAP expression after hypoxic injury. Neurosci Lett 576: 45-50. doi: 10.1016/j.neulet.2014.05.053
    [39] Berg A, Zelano J, Pekna M, et al. (2013) Axonal regeneration after sciatic nerve lesion is delayed but complete in GFAP- and vimentin-deficient mice. PloS One 8: e79395. doi: 10.1371/journal.pone.0079395
    [40] Triolo D, Dina G, Lorenzetti I, et al. (2006) Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage. J Cell Sci 119: 3981-3993. doi: 10.1242/jcs.03168
    [41] Myllykoski M, Seidel L, Muruganandam G, et al. (2015) Structural and functional evolution of 2',3'-cyclic nucleotide 3'-phosphodiesterase. Brain Res 1641: 64.
    [42] Micera A, Lambiase A, Stampachiacchiere B, et al. (2007) Nerve growth factor and tissue repair remodeling: trkA(NGFR) and p75(NTR), two receptors one fate. Cytokine Growth Factor Rev 18: 245-256. doi: 10.1016/j.cytogfr.2007.04.004
    [43] Tomita K, Kubo T, Matsuda K, et al. (2007) The neurotrophin receptor p75NTR in Schwann cells is implicated in remyelination and motor recovery after peripheral nerve injury. Glia 55: 1199-1208. doi: 10.1002/glia.20533
    [44] Zhang Y, Lv J, Guo H, et al. (2015) Hypoxia-induced proliferation in mesenchymal stem cells and angiotensin II-mediated PI3K/AKT pathway. Cell Biochem Funct 33: 51-58. doi: 10.1002/cbf.3080
    [45] Andreeva ER, Lobanova MV, Udartseva OO, et al. (2015) Response of Adipose Tissue-Derived Stromal Cells in Tissue-Related O2 Microenvironment to Short-Term Hypoxic Stress. Cells Tissues Organs 200: 307. doi: 10.1159/000438921
    [46] Phillips JB (2014) Monitoring neuron and astrocyte interactions with a 3D cell culture system. Methods Mol Biol 1162: 113-124. doi: 10.1007/978-1-4939-0777-9_9
    [47] Smith R, Bagga V, Fricker-Gates RA (2003) Embryonic neural progenitor cells: the effects of species, region, and culture conditions on long-term proliferation and neuronal differentiation. J Hematothe Stem Cell Res 12: 713-725. doi: 10.1089/15258160360732731
  • Reader Comments
  • © 2017 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(3126) PDF downloads(848) Cited by(0)

Article outline

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog